Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

AcelRx Pharmaceuticals Inc (R5XA.BE)

Compare
0.4175
-0.0095
(-2.22%)
At close: April 17 at 9:40:05 PM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for R5XA.BE

Recent News: R5XA.BE

View More
Talphera Inc (TLPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Insights

Talphera Inc (TLPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Insights
GuruFocus.com 19 days ago
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
PR Newswire 19 days ago
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million
PR Newswire 19 days ago
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
PR Newswire 24 days ago
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
PR Newswire 3 months ago
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
PR Newswire 4 months ago
Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023)

Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023)
Simply Wall St. 4 months ago
Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges

Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges
GuruFocus.com 5 months ago
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
PR Newswire 5 months ago
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
PR Newswire 5 months ago
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
PR Newswire 6 months ago
View More

Related Tickers

MRKC.DU Merck KGaA
22.80
-0.87%
 
MRKC.SG Merck KGaA
22.80
-0.87%
 
MRKC.F Merck KGaA
23.20
+0.87%
 
EVT.VI Evotec SE
6.24
+7.21%
 
BON.F Boiron SA
23.55
-1.05%
 
BIO.RO Biofarm S.A.
0.6700
-0.30%
 
131030.KQ DHP Korea Co., Ltd.
6,280.00
+1.13%
 
MRKC.MU Merck KGaA
23.20
0.00%
 
EVT.DU Evotec SE
6.37
+9.87%
 
ATB.RO Antibiotice S.A.
2.0900
+0.72%